DALT
Diallyltryptamine, also known as N,''N''-diallyltryptamine, is a tryptamine derivative which has been identified as a designer drug.Use and effects
According to Alexander Shulgin in his book TiHKAL, the dose of DALT is greater than 40mg orally and its duration is unknown. Its effects were not described. Per Stephen Szara and colleagues in much earlier publications however, DALT and other extended N,''N''-dialkyltryptamines produce similar effects to dimethyltryptamine but are longer-lasting, with durations of up to 3hours.Interactions
Pharmacology
Pharmacodynamics
The receptor interactions of DALT have been studied. The drug produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.Chemistry
DALT has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.Synthesis
The chemical synthesis of DALT has been described.Analogues
s of DALT include 4-HO-DALT, 4-AcO-DALT, 5-MeO-DALT, methylallyltryptamine, propylallyltryptamine, and isopropylallyltryptamine, among others.History
DALT was first described in the scientific literature by Stephen Szara and colleagues by 1962.DALT is not an explicitly nor implicitly controlled substance in Canada as of 2025.DALT is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.